Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer

Natural killer (NK) cells are attractive effectors for adoptive immunotherapy of cancer. Results from first-in-human studies using chimeric antigen receptor (CAR)-engineered primary NK cells and NK-92 cells are encouraging in terms of efficacy and safety. In order to further improve treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Murali Shankar, Nivedha, Ortiz-Montero, Paola, Kurzyukova, Anastasia, Rackwitz, Wiebke, Künzel, Stephan R., Wels, Winfried S., Tonn, Torsten, Knopf, Franziska, Eitler, Jiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599014/
https://www.ncbi.nlm.nih.gov/pubmed/37885894
http://dx.doi.org/10.3389/fimmu.2023.1254821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599014/
https://www.ncbi.nlm.nih.gov/pubmed/37885894
http://dx.doi.org/10.3389/fimmu.2023.1254821

Ejemplares similares